ReviewHNO2025
[Hearing aid provision and quality assurance].
Review in HNO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and preliminary evaluation of a German questionnaire assessing attitudes toward hearing aids and behavioral intention.BMC health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Approximately 17.1% of the German population, so around 12.1 million people, suffer from hearing loss; however, only around 3.7 million of them have a hearing aid. Inadequately treated hearing loss not only has an enormous impact on quality of life but also causes extremely high costs. A meta-analysis of many European countries estimated that untreated hearing loss costs Europe 216 billion euros every year. Hearing system provision can significantly improve health and, above all, quality of life, while untreated hearing loss can lead to social isolation, depression, and premature cognitive decline-consequences that adequate provision can prevent. This overview provides a summary of the indications for and provision of a hearing system and discusses how these should be checked in terms of quality assurance in order to provide the best possible care to people with hearing loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.